Seer Inc (SEER)
2.115
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
2.115
0.00 (0.00%)
After-Hours: 20:00
Seer Enterprise Value: -170.88M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 16, 2024 | -170.88M |
| May 15, 2024 | -169.59M |
| May 14, 2024 | -168.29M |
| May 13, 2024 | -179.33M |
| May 10, 2024 | -179.00M |
| May 09, 2024 | -174.78M |
| May 08, 2024 | -163.74M |
| May 07, 2024 | -165.04M |
| May 06, 2024 | -163.09M |
| May 03, 2024 | -163.09M |
| May 02, 2024 | -168.29M |
| May 01, 2024 | -170.88M |
| April 30, 2024 | -173.48M |
| April 29, 2024 | -181.92M |
| April 26, 2024 | -184.52M |
| April 25, 2024 | -194.91M |
| April 24, 2024 | -193.61M |
| April 23, 2024 | -191.01M |
| April 22, 2024 | -200.11M |
| April 19, 2024 | -200.76M |
| April 18, 2024 | -194.91M |
| April 17, 2024 | -198.81M |
| April 16, 2024 | -194.91M |
| April 15, 2024 | -192.31M |
| April 12, 2024 | -189.07M |
| Date | Value |
|---|---|
| April 11, 2024 | -196.21M |
| April 10, 2024 | -194.26M |
| April 09, 2024 | -194.26M |
| April 08, 2024 | -196.21M |
| April 05, 2024 | -196.86M |
| April 04, 2024 | -196.86M |
| April 03, 2024 | -190.37M |
| April 02, 2024 | -193.61M |
| April 01, 2024 | -187.12M |
| March 31, 2024 | -185.17M |
| March 28, 2024 | -193.15M |
| March 27, 2024 | -190.56M |
| March 26, 2024 | -197.69M |
| March 25, 2024 | -192.51M |
| March 22, 2024 | -193.15M |
| March 21, 2024 | -193.15M |
| March 20, 2024 | -191.21M |
| March 19, 2024 | -191.86M |
| March 18, 2024 | -193.80M |
| March 15, 2024 | -187.97M |
| March 14, 2024 | -199.63M |
| March 13, 2024 | -193.15M |
| March 12, 2024 | -191.86M |
| March 11, 2024 | -189.27M |
| March 08, 2024 | -180.85M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-237.42M
Minimum
Nov 16 2023
4.694B
Maximum
Dec 10 2020
641.43M
Average
59.28M
Median
Apr 27 2022
Enterprise Value Benchmarks
| Candel Therapeutics Inc | 358.58M |
| CEL-SCI Corp | 72.33M |
| AIM ImmunoTech Inc | 7.080M |
| IGC Pharma Inc | 36.73M |
| NovaBay Pharmaceuticals Inc | 5.209M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -20.68M |
| Revenue (Quarterly) | 3.03M |
| Total Expenses (Quarterly) | 28.22M |
| EPS Diluted (Quarterly) | -0.32 |
| Gross Profit Margin (Quarterly) | 43.73% |
| Profit Margin (Quarterly) | -682.5% |
| Earnings Yield | -61.47% |
| Normalized Earnings Yield | -61.47 |